|
1
|
Small W Jr, Bacon MA, Bajaj A, Chuang LT,
Fisher BJ, Harkenrider MM, Jhingran A, Kitchener HC, Mileshkin LR,
Viswanathan AN and Gaffney DK: Cervical cancer: A global health
crisis. Cancer. 123:2404–2412. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Torre LA, Bray F, Siegel RL, Ferlay J,
Lortet-Tieulent J and Jemal A: Global cancer statistics, 2012. CA
Cancer J Clin. 65:87–108. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Wang J, Lv H, Xue Z, Wang L and Bai Z:
Temporal trends of common female malignances on breast, cervical,
and ovarian cancer mortality in japan, republic of Korea, and
Singapore: Application of the age-period-cohort model. Biomed Res
Int. 2018:53074592018.PubMed/NCBI
|
|
4
|
Gupta S, Kumar P and Das BC: HPV:
Molecular pathways and targets. Curr Probl Cancer. 42:161–174.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Drusco A and Croce CM: MicroRNAs and
cancer: A long story for short RNAs. Adv Cancer Res. 135:1–24.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Fanini F and Fabbri M: Cancer-derived
exosomic microRNAs shape the immune system within the tumor
microenvironment: State of the art. Semin Cell Dev Biol. 67:23–28.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Costello A, Lao N, Clynes M and Barron N:
Conditional knockdown of endogenous MicroRNAs in CHO cells using
TET-ON-SanDI sponge vectors. Methods Mol Biol. 1603:87–100. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Höck J and Meister G: The Argonaute
protein family. Genome Biol. 9:2102008. View Article : Google Scholar
|
|
9
|
Lin X, Xiaoqin H, Jiayu C, Li F, Yue L and
Ximing X: Long non-coding RNA miR143HG predicts good prognosis and
inhibits tumor multiplication and metastasis by suppressing
mitogen-activated protein kinase and Wnt signaling pathways in
hepatocellular carcinoma. Hepatol Res. 49:902–918. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Zhang M, Wang C and Mu L: Mir-148a induces
apoptosis by upregulating bim expression in gastric cancer cells.
Int J Clin Exp Med. 10:2791–2799. 2017.PubMed/NCBI
|
|
11
|
Liu J, Si L and Tian H: MicroRNA-148a
inhibits cell proliferation and cell cycle progression in lung
adenocarcinoma via directly targeting transcription factor E2F3.
Exp Ther Med. 16:5400–5409. 2018.PubMed/NCBI
|
|
12
|
Xiao WD, Ao J, Huang Z, Lin SR, Peng L and
Li Y: The effects of up-regulation of miR-148a on the expression of
anti-oncogene ppENK, p16 and RASSF1A in pancreatic carcinoma AsPC-1
cells. Pancreatology. 16 (Suppl):S152016. View Article : Google Scholar
|
|
13
|
Zhang H, Li Y, Huang Q, Ren X, Hu H, Sheng
H and Lai M: MiR-148a promotes apoptosis by targeting Bcl-2 in
colorectal cancer. Cell Death Differ. 18:1702–1710. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Wu XL and Zheng PS: Undifferentiated
embryonic cell transcription factor-1 (UTF1) inhibits the growth of
cervical cancer cells by transactivating p27 Kip1. Carcinogenesis.
34:1660–1668. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Bock C, Reither S, Mikeska T, Paulsen M,
Walter J and Lengauer T: BiQ Analyzer: Visualization and quality
control for DNA methylation data from bisulfite sequencing.
Bioinformatics. 21:4067–4068. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Han M, Li J, Cao Y, Huang Y, Li W, Zhu H,
Zhao Q, Han JJ, Wu Q, Li J, et al: A role for LSH in facilitating
DNA methylation by DNMT1 through enhancing UHRF1 chromatin
association. Nucleic Acids Res. 48:12116–12134. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Wei Y, Peng S, Wu M, Sachidanandam R, Tu
Z, Zhang S, Falce C, Sobie EA, Lebeche D and Zhao Y: Multifaceted
roles of miR-1s in repressing the fetal gene program in the heart.
Cell Res. 24:278–292. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Yu X and Li Z: The role of microRNAs
expression in laryngeal cancer. Oncotarget. 6:23297–23305. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Li Y, Deng X, Zeng X and Peng X: The role
of Mir-148a in cancer. J Cancer. 7:1233–1241. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Zhao W, Zheng J, Wei G, Yang K, Wang G and
Sun X: miR-148a inhibits cell proliferation and migration through
targeting ErbB3 in colorectal cancer. Oncol Lett. 18:2530–2536.
2019.PubMed/NCBI
|
|
22
|
Zuo J, Xia J, Ju F, Yan J, Zhu A, Jin S,
Shan T and Zhou H: MicroRNA-148a can regulate runt-related
transcription factor 3 gene expression via modulation of DNA
methyltransferase 1 in gastric cancer. Mol Cells. 35:313–319. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Pantazis G, Harter PN, Capper D, Kohlhof
P, Mittelbronn M and Schittenhelm J: The embryonic stem cell factor
UTF1 serves as a reliable diagnostic marker for germinomas.
Pathology. 46:225–229. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Okuda A, Fukushima A, Nishimoto M, Orimo
A, Yamagishi T, Nabeshima Y, Kuro-o M, Nabeshima Yi, Boon K,
Keaveney M, et al: UTF1, a novel transcriptional coactivator
expressed in pluripotent embryonic stem cells and extra-embryonic
cells. EMBO J. 17:2019–2032. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Jin B and Robertson KD: DNA
Methyltransferases, DNA damage repair, and cancer. Adv Exp Med
Biol. 754:3–29. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Foltz G, Yoon JG, Lee H, Ryken TC,
Sibenaller Z, Ehrich M, Hood L and Madan A: DNA
methyltransferase-mediated transcriptional silencing in malignant
glioma: A combined whole-genome microarray and promoter array
analysis. Oncogene. 28:2667–2677. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Scopa CD, Zolota V and Kourea HP: Targeted
pathways in breast cancer: Molecular and protein markers guiding
therapeutic decisions. Curr Mol Pharmacol. 7:4–21. 2014.PubMed/NCBI
|
|
28
|
Kumar R and Rao DN: Role of DNA
Methyltransferases in epigenetic regulation in bacteria. Subcell
Biochem. 61:81–102. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Subramaniam D, Thombre R, Dhar A and Anant
S: DNA Methyltransferases: A novel target for prevention and
therapy. Front Oncol. 4:80. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
You Y, Yang W, Wang Z, Zhu H, Li H, Lin C
and Ran Y: Promoter hypermethylation contributes to the frequent
suppression of the CDK10 gene in human nasopharyngeal carcinomas.
Cell Oncol (Dordr). 36:323–331. 2013. View Article : Google Scholar : PubMed/NCBI
|
